Spinal disc herniation

Ultra-minimally invasive spine surgery now performed by Midwest Orthopaedics at RUSH in Chicago

Retrieved on: 
星期三, 五月 1, 2024
Pain, Spinal stenosis, Sciatica, Spinal disc herniation, Spine, Patient, Skin, ESS, Physician, RUSH

CHICAGO, May 1, 2024 /PRNewswire/ -- Bringing peace of mind to patients needing spine surgery, an ultra-minimally invasive procedure called endoscopic spine surgery (ESS) is now being performed in Chicago by Dr. Kern Singh of Midwest Orthopaedics at RUSH, a pioneer in the use of this new technique. ESS is considered the 'next generation' of minimally invasive spine surgery because it requires no incisions at all, allowing patients to recover even more quickly.

Key Points: 
  • CHICAGO, May 1, 2024 /PRNewswire/ -- Bringing peace of mind to patients needing spine surgery, an ultra-minimally invasive procedure called endoscopic spine surgery (ESS) is now being performed in Chicago by Dr. Kern Singh of Midwest Orthopaedics at RUSH, a pioneer in the use of this new technique.
  • ESS is considered the 'next generation' of minimally invasive spine surgery because it requires no incisions at all, allowing patients to recover even more quickly.
  • Click here to view video of the endoscopic spine procedure performed by Dr. Singh.
  • "Endoscopic spine surgery is being performed by just a small number of specially trained physicians in the country," explains Dr. Singh.

Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at ASIPP 2024

Retrieved on: 
星期一, 四月 8, 2024
Biotechnology, Men, Health, Consumer, Other Health, Pharmaceutical, Surgery, Other Science, Research, Medical Devices, Science, Women, Seniors, Clinical Trials, Week, Sciatica, LDH, Incidence, Ferring Pharmaceuticals, Patient, Spinal disc herniation, Șaeș, University, ESI, Quality of life, Manager, University of Illinois Urbana-Champaign, Society, Back pain, LSM, Pain, SAE

"Based on these findings, SI-6603 could provide another option where a single injection to the lumbar disc could offer patients significant relief from the unrelenting pain often associated with lumbar disc herniation."

Key Points: 
  • "Based on these findings, SI-6603 could provide another option where a single injection to the lumbar disc could offer patients significant relief from the unrelenting pain often associated with lumbar disc herniation."
  • An analysis assessing current treatment patterns and gaps in clinical management of patients with newly diagnosed LDH was also presented.
  • The analysis reviewed medical claims data of more than a million U.S. patients over a four-year period.
  • Among patients who received more than one ESI, one in five (22.4%) underwent surgery with 14.2% of those patients receiving repeated surgeries.

Herniated Disc Surgery Specialists of NYC (Manhattan, NY) Now Offering Telehealth Consultations

Retrieved on: 
星期二, 三月 19, 2024
Diagnosis, Harvard Business Review, COVID-19, Patient, Anatomy, Laminectomy, Spinal disc herniation, Laminoplasty

NEW YORK, March 19, 2024 /PRNewswire-PRWeb/ -- Herniated Disc Surgery Specialists of NYC, located in Manhattan, New York announced today that the herniated disc specialty surgery practice will now offer patients virtual consultations. Dr. Sean McCance, founder and medical director of the Herniated Disc Surgery Specialists of NYC, noted, "The need for telehealth consultations remains ever-present and unwavering since the start of the COVID-19 pandemic".

Key Points: 
  • Herniated Disc Surgery Specialists of NYC, located in Manhattan, New York announced today that the herniated disc specialty surgery practice will now offer patients virtual consultations.
  • Dr. Sean McCance, founder and medical director of the Herniated Disc Surgery Specialists of NYC, noted, "The need for telehealth consultations remains ever-present and unwavering since the start of the COVID-19 pandemic".
  • NEW YORK, March 19, 2024 /PRNewswire-PRWeb/ -- Herniated Disc Surgery Specialists of NYC , located in Manhattan, New York announced today that the herniated disc specialty surgery practice will now offer patients virtual consultations.
  • Dr. Sean McCance, founder and medical director of the Herniated Disc Surgery Specialists of NYC, noted, "The need for telehealth consultations remains ever-present and unwavering since the start of the COVID-19 pandemic".

HSS Orthopedics with Stamford Health Establishes Premier Spine Center in Connecticut

Retrieved on: 
星期一, 二月 26, 2024
Robotics, FACS, Neck, Spinal fusion, Spine, Neurosurgery, Hospital for Special Surgery, Specialization, Quality of life, Chronic pain, Pain, Hospital, Tennis, Injury, MBA, Common, Human, HSS, Neuro, Arthritis, Pain management, Spinal disc herniation, Back pain, Patient, Ageing, Neurology, Scoliosis, Osteoporosis, Nursing

STAMFORD, Conn., Feb. 26, 2024 /PRNewswire/ -- Back pain is a complex, widespread issue across the United States, with the Centers for Disease Control and Prevention estimating that 65 million Americans are affected. Common reasons include arthritis, disc and nerve injury, muscle strain, and other underlying health conditions such as osteoporosis and scoliosis. Responding to the urgent need for increased access to high quality spine care in Connecticut, a specialist center was created last year as an extension of the collaboration between Hospital for Special Surgery (HSS) and Stamford Health.

Key Points: 
  • Responding to the urgent need for increased access to high quality spine care in Connecticut, a specialist center was created last year as an extension of the collaboration between Hospital for Special Surgery (HSS) and Stamford Health.
  • The HSS Spine Center with Stamford Health led by co-medical directors Steven J. McAnany, MD , spine surgeon at HSS, and Andrea F. Douglas, MD, FAANS, FACS , chief of Neurosurgery at Stamford Health, builds on a successful collaboration started in 2016.
  • "The HSS Spine Center with Stamford Health harnesses the expertise of our respective institutions to bring world-class patient care to the communities we serve," said Kathleen Silard, president and CEO at Stamford Health.
  • "Over the past year, hundreds of patients with back and neck conditions have benefitted from the exceptional capabilities and proven expertise we offer through the HSS Spine Center with Stamford Health."

Top-trained Spine Surgeons Provide Free Patient Guide for Artificial Disc Replacement, Available at CentersForArtificialDisc.com

Retrieved on: 
星期五, 九月 22, 2023
Spinal fusion, Scoliosis, Human, Male, Surgeon, Anatomy, Spinal disc herniation, Rotation, North American Spine Society, Foot, Spine, Research, Neck, NASS, Paralysis, Walking, MD, Patient, FDA, Bias, Hand, Medical device

But recent spine research studies have changed that, however, as new FDA-approved artificial disc implant designs have been released over the last three years.

Key Points: 
  • But recent spine research studies have changed that, however, as new FDA-approved artificial disc implant designs have been released over the last three years.
  • "Spine research studies have shown that artificial disc replacement preserves the natural motion and can reduce the need for surgery at other levels in the neck.
  • "Sadly, the patient may receive a dated treatment because a surgeon isn't trained in artificial disc replacement," explains Dr. Lynch, who was one of the first spine surgeons in Nevada to be trained in artificial disc replacement surgery.
  • The free 20-page Patient Guide explains the limitations of spinal fusion as well as the pros and cons of artificial disc replacement.

Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.

Retrieved on: 
星期一, 七月 24, 2023
Professional Services, Medical Devices, Health, Surgery, Other Health, Finance, Spinal fusion, SST, Investigational New Drug, PIPE, PLLC, Arthroplasty, I Am the Moon, Back pain, Prospectus, Acquisition, Degenerative disc disease, Patient, Investigational device exemption, Clinical, Spinal disc herniation, Ides, Security (finance), IDE, FDA, NYSE, Medical device

Spinal Stabilization Technologies (“SST” or the “Company”), a medical device company, and BlueRiver Acquisition Corp. ("BlueRiver") (NYSE AM: BLUA), a publicly traded special purpose acquisition company, have entered into a definitive business combination agreement.

Key Points: 
  • Spinal Stabilization Technologies (“SST” or the “Company”), a medical device company, and BlueRiver Acquisition Corp. ("BlueRiver") (NYSE AM: BLUA), a publicly traded special purpose acquisition company, have entered into a definitive business combination agreement.
  • Upon the closing of the proposed transaction between SST and BlueRiver, the combined company will operate as Spinal Stabilization Technologies and be listed on an approved stock exchange.
  • The PerQdisc is an investigational device in the U.S. and has not been approved by the FDA.
  • SST's pioneering work has positioned it to be at the forefront of the market for Augmented Discectomy and Degenerative Disc Disease treatments.

Ferring Announces Positive Topline Phase 3 Results for SI-6603, an Investigational Treatment for Lumbar Disc Herniation

Retrieved on: 
星期五, 五月 26, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, FDA, Clinical Trials, Comparison, Biologics license application, Ferring Pharmaceuticals, Visual analogue scale, Sciatica, Hope, VAS, Spinal disc herniation, Patient, MPH, BLA, Pharmaceutical industry, MD

Ferring Pharmaceuticals (Ferring) announced that its clinical development partner, Seikagaku Corporation (Seikagaku), achieved positive topline results for its registrational Phase 3 clinical trial of SI-6603, an investigational treatment for lumbar disc herniation (generic name: Condoliase).

Key Points: 
  • Ferring Pharmaceuticals (Ferring) announced that its clinical development partner, Seikagaku Corporation (Seikagaku), achieved positive topline results for its registrational Phase 3 clinical trial of SI-6603, an investigational treatment for lumbar disc herniation (generic name: Condoliase).
  • The study was a randomized, double-blind, controlled, parallel-group, comparative study of SI-6603 in 352 patients with lumbar disc herniation.
  • Ferring plans to commercialize the product in the United States and has received further rights to develop, register and commercialize SI-6603 worldwide, excluding Japan.
  • “The positive topline results offer the hope of a non-surgical treatment option for patients and their healthcare providers.”

Locate Bio’s LDGraft Granted FDA Breakthrough Device Designation

Retrieved on: 
星期四, 五月 18, 2023
Medical Devices, FDA, Health, Surgery, Pharmaceutical, Biotechnology, Spinal fusion, Surgeon, Low back pain, Bio, Degenerative disc disease, Disability, Myelopathy, Quality of life, Bone morphogenetic protein 2, Spinal disc herniation, Radiculopathy, Patient, DDD, Diagnosis, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Spinal stenosis, Pharmaceutical industry, Locate

Locate Bio, a UK-based orthobiologics company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for LDGraft, currently in development for anterior lumbar interbody spinal fusion (ALIF) procedures at one level from L3-S1 for patients with degenerative disc disease.

Key Points: 
  • Locate Bio, a UK-based orthobiologics company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for LDGraft, currently in development for anterior lumbar interbody spinal fusion (ALIF) procedures at one level from L3-S1 for patients with degenerative disc disease.
  • The FDA Breakthrough Device Program is designed to accelerate patient access to promising technologies that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions.
  • We are delighted therefore to have been granted a Breakthrough Device designation from the FDA for LDGraft, our exciting controlled and extended-release rhBMP-2 for spinal fusion.
  • We are proud that the FDA has recognised the potential of LDGraft.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon

Retrieved on: 
星期二, 五月 9, 2023
Epidural steroid injection, Injection, Human, Sport, Portland Marathon, Arm, University, Cranial nerves, MLSS, Professional Rodeo Cowboys Association, History of the Portland Timbers franchise, University of Maryland, College Park, Baltimore Orioles, Baltimore Ravens broadcasters, Spine, Regenerative medicine, History of the University of Maryland, College Park, PRCA, Incidence, MD, Patient, Patient safety, Risk, Internal medicine, Pain management, Disease, ESI, Spinal disc herniation, American College, Baltimore Ravens, NYSE, Radiation exposure, Spinal stenosis, Safety, Injury, Dentistry, Birth control, Sports medicine, Portland Beavers

Dr. Huebert initially conducted seven cases using the CompuFlo Epidural system, in which he reported 100% success.

Key Points: 
  • Dr. Huebert initially conducted seven cases using the CompuFlo Epidural system, in which he reported 100% success.
  • The evaluation included Epidural Steroid Injection (ESI) procedures in the lumbar, thoracic and cervical thoracic junctions in the spine.
  • He specializes in non-surgical orthopedic, spine, sports and other painful injuries and conditions utilizing a variety of therapies including traditional and regenerative medicine.
  • Based on the growing recognition of our technology among leading pain management specialists, we remain confident that the CompuFlo Epidural system will, in time, become the standard of care in epidural analgesia.”

Team Novo Nordisk welcome Kate Brim as ambassador for 2023

Retrieved on: 
星期三, 五月 3, 2023
Tetraplegia, Diabetes, Life, World championship, World cup, Spinal disc herniation, Spinal cord, Kate, Rehabilitation, Pain, Athlete, Team Novo Nordisk, Community, Type 1, Diagnosis, Pan-American Para Table Tennis Championships, Character, Sports equipment, Entertainment, Hatmaking, United States national team

ATLANTA, May 3, 2023 /PRNewswire-PRWeb/ -- World Champion Handcyclist Kate Brim joins the world's first all diabetes professional cycling team as a sponsored athlete for 2023 as the American Para athlete continue her rapid rise to the top of her sport and targets more success in Para-cycling.

Key Points: 
  • "We're absolutely over the moon to be able to welcome Kate Brim to the Team Novo Nordisk family," began CEO & Co-Founder Phil Southerland.
  • "As soon as I heard about Kate I knew that Team Novo Nordisk was the right place for her.
  • "I am so incredibly honored to join Team Novo Nordisk," said Brim.
  • "Community is of huge importance to me and as I continue to learn and develop, I'm looking forward to being part of the Team Novo Nordisk family."